Norvax Compact PD is a monovalent vaccine (0.1ml dose) containing inactivated Salmon pancreas disease virus (SPDV) strain F93-125, to protect against Pancreas Disease in Atlantic Salmon (Salmo salar).
Emulsion for injection
Salmon pancreas disease virus (SPDV) strain F93-125, ≥ 70 % RPP*
* RPP : relative percentage protection in a laboratory potency test in Atlantic salmon
Indications for use
For the active immunisation of Atlantic salmon to reduce heart lesions, mortality and weight loss caused by Pancreas disease. Onset of immunity: 500 degrees days.
Duration of immunity: at least 12 months for reduction of heart lesions; 18 months for reduction of mortality and weight loss.
Zero degree days
500 ml bottles of polyethylene terephthalate (PET) closed with a rubber stopper and aluminium cap, containing 5000 doses.
For full information please refer to the product data sheet. Further information is available on request.
Use Medicines Responsibly. For more information please refer to the Responsible Use sections of the NOAH website.
If you are not the prescribing veterinary surgeon, advice should be sought from the medicine prescriber.
Date of preparation: January 2018